US FDA Requests Frequent Updates On Supply Chain Disruptions In COVID-19 Era
Executive Summary
Pharmaceutical companies struggling to keep up with coronavirus-related supply chain havoc asked to keep the US regulator informed as situation unfolds.
You may also be interested in...
To Prevent Shortages, US FDA Wants Sponsor To Provide Notifications Of Demand Spike
Demand-related shortages are a relatively new problem, but the FDA maintains their tools can prevent or end them.
To Prevent Shortages, US FDA Wants Notices From Drug Firms On Spikes In Demand
Demand-related shortages are a relatively new problem, but FDA maintains its tools can prevent or end them.
To Prevent Shortages, US FDA Wants Sponsor To Provide Notifications Of Demand Spike
Demand-related shortages are a relatively new problem, but the FDA maintains their tools can prevent or end them.